All MYC+RUNX2-DKO mice died 1 month post-transplantation (Fig. 7c), whereas there were no lethal hematological malignancies in MYC+RUNX2-WT or DKO mice 6 months post-transplantation. Here, RUNX2 is linked to hematologic disorder.